[Immunocorrecting therapy in focal scleroderma].
Suchkova
T N
TN
Prozorovskaia
N N
NN
Suchkov
S V
SV
Del'vig
A A
AA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D003094:Collagen / Q000378:metabolism; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000627:therapeutic use*; D012594:Scleroderma, Localized / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin; D003094:Collagen; D006909:Hydroxyproline
Immunokorrigiruiushchaia terapiia pri ochagovoĭ sklerodermii.